immunotherapy

Open Access
Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer
Nawaz Khan, Umar Raza, Syed Aqib Ali Zaidi, Muhadaisi Nuer, Kayisaier Abudurousuli, Yipaerguli Paerhati, Alifeiye Aikebaier and Wenting Zhou

Cancer Biology & Medicine July 2025, 22 (7) 762-788; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0122
Open Access
High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
Yuling Xiao, Hang Zhang, Yi Xiao, Ying Wang, Jing Zhang, Qi Hua, Pengchen Hu, Xinyan Lyu, Weihua Shou, Xin Hu, Zhiming Shao, Yizhou Jiang, Wei Huang and Jinxiu Shi

Cancer Biology & Medicine July 2025, 22 (7) 854-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0038
Open Access
Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma
Tianshu Yu, Xianhuo Wang, Ou Bai, Huilai Zhang and Wenbin Qian

Cancer Biology & Medicine April 2025, 22 (4) 301-321; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0538
Open Access
Neoepitope BTLA^P267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma
Fang Liu, Hua Chen, Suxin Wu, Chenlu Zhu, Mingji Zhang, Wei Rui, Dong Zhou, Yang Wang, Xin Lin, Xueqiang Zhao and Yunbin Ye

Cancer Biology & Medicine April 2025, 22 (4) 412-432; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0434
Open Access
Optimal immunotherapy duration in advanced NSCLC: defining the ideal treatment window
Kaibo Ding, Dujiang Liu, Xinyue Li, Zhongsheng Peng, Lin Zhu and Yanjun Xu

Cancer Biology & Medicine March 2025, 22 (3) 284-294; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0457
Open Access
Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy
Heliang Wu, Yi Wang, Yulin Lin, Ru Ma, Xuemei Du, Yandong Su, Rui Yang, Zhiran Yang, Xinli Liang, Yinguang Zhang, Xiaoqing Liang, Zhonghe Ji, Chunning Lai, Yajing Huang and Yan Li

Cancer Biology & Medicine November 2024, 21 (11) 1078-1094; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0218
Open Access
Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies
Mao Zhang, Haokai Qin, Yingcheng Wu and Qiang Gao

Cancer Biology & Medicine October 2024, 21 (10) 849-863; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0192
Open Access
Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma
Jiaxin Han, Wentao Kuai, Liu Yang, Xuemei Tao, Yuekui Wang, Minghui Zeng, Yuqin Li, Yuqiang Mi, Ningning Zhang, Wei Lu and Liang Xu

Cancer Biology & Medicine September 2024, 21 (9) 813-825; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0048
Open Access
Immune checkpoint inhibitors: breakthroughs in cancer treatment
Xueqing Kong, Jinyi Zhang, Shuwei Chen, Xianyang Wang, Qing Xi, Han Shen and Rongxin Zhang

Cancer Biology & Medicine June 2024, 21 (6) 451-472; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0055
Open Access
Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells
Zhang Fang, Xinyi Ding, Hao Huang, Hongwei Jiang, Jingting Jiang and Xiao Zheng

Cancer Biology & Medicine June 2024, 21 (6) 499-512; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0105

Main menu

User menu

Search

immunotherapy

Pages

Navigate

More Information

For Authors

Journal Services